High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in copd exacerbation: a multicenter non-inferiority randomized trial

HIGHLIGHTS

• who: Andrea Cortegiani from the Department of Surgical, Oncological and Oral Science (DiChir.On.S.), University of Palermo, Palermo, Italy have published the paper: High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial, in the Journal: (JOURNAL) of December/12,/2017
• what: The authors included patients with mild-to-moderate AECOPD for two reasons: the efficacy and safety of HFNT in AECOPD have not been demonstrated so far ; NIV is considered the gold standard respiratory support for managing patients with AECOPD with highquality evidence . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.